Profil
John E.
Doherty was the founder who founded Protalex, Inc. in 1999 and held the title of Independent Director from 1999 to 2014.
Ehemalige bekannte Positionen von John E. Doherty
| Unternehmen | Position | Ende |
|---|---|---|
| PROTALEX, INC. | Gründer | 04.02.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Protalex, Inc.
 Protalex, Inc. Pharmaceuticals: MajorHealth Technology Protalex, Inc. engages in the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis and Immune Thrombocytopenia. Its lead product is PRTX-100 which is a bacterial protein known to modify aspects of the human immune system. The company was founded by John E. Doherty on September 17, 1999 and is headquartered in Florham Park, NJ. | Health Technology |
